# clm_2E82AF12DD3E

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_operating_income  
value: 1,542,000,000 United States dollar  
valid_from: 2023-06-30  
valid_to: 2023-09-30  
published: 2023-08-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B41FB990A838  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly operating income: 1,542,000,000 United States dollar", as of 2023-06-30 (until 2023-09-30). Claim clm_2E82AF12DD3E, https://asof.is/claim/clm_2E82AF12DD3E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm (primary, SEC EDGAR 10-Q Q2 FY2023, published 2023-08-03)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_operating_income | 1,509,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_2E82AF12DD3E](/claim/clm_2E82AF12DD3E.md) | [clm_4B304DFC779C](/claim/clm_4B304DFC779C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.